University of Minnesota. Driven to Discover.
The AMR Industry Alliance says more commitment and funding are needed.
Researchers identify more than 80 genes that contribute to resistance.
Four research teams from India receive awards for point-of-care diagnostic tests, 3 of them focused on sepsis.
A review finds the biomarker cut mortality and antibiotic exposure in patients with acute respiratory infections.
Recommendations focus on public-private R&D funding, incentives, and other steps.
Point-of-care tests, shared decision making, and procalcitonin-guided therapy were singled out.
Two companies that have received funds—Spero Therapeutics and Entasis Therapeutics—say CARB-X support has been instrumental.
"If we can eradicate the empirical use of antibiotics . . . we can achieve a lot," Zowawi says.
Visit the ASP Diagnostics page
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyAcademic Health Center, University of Minnesota, Minneapolis, MN
© 2018 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.